Abstract
Autoimmune connective tissue diseases are frequently in the differential diagnosis when patients present with cutaneous eruptions and systemic complaints. Systemic-onset juvenile idiopathic arthritis, systemic lupus erythematosus, and juvenile dermatomyositis are three autoimmune disorders that may have prominent cutaneous findings. Recognition of the characteristic skin manifestations may be critical in ordering the appropriate workup and making the correct diagnosis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child. 2001;85(5):421–6. Epub 2001/10/23.
Stephan JL, Kone-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology. 2001;40(11):1285–92. Epub 2001/11/16.
Zeft A, Hollister R, LaFleur B, Sampath P, Soep J, McNally B, et al. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience. J Clin Rheumatol. 2009;15(4):161–4. Epub 2009/04/14.
Lequerre T, Quartier P, Rosellini D, Alaoui F, De Bandt M, Mejjad O, et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis. 2008;67(3):302–8. Epub 2007/10/20.
Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S, et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet. 2008;371(9617):998–1006. Epub 2008/03/25.
De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367(25):2385–95. Epub 2012/12/21.
Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–86. Epub 2012/05/04.
Mina R, Brunner HI. Pediatric lupus—are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? Rheum Dis Clin North Am. 2010;36(1):53–80, vii–viii. Epub 2010/03/06.
Gerami P, Walling HW, Lewis J, Doughty L, Sontheimer RD. A systematic review of juvenile-onset clinically amyopathic dermatomyositis. Br J Dermatol. 2007;157(4):637–44. Epub 2007/06/29.
Sallum AM, Pivato FC, Doria-Filho U, Aikawa NE, Liphaus BL, Marie SK, et al. Risk factors associated with calcinosis of juvenile dermatomyositis. J Pediatr. 2008;84(1):68–74. Epub 2008/01/11.
Tomasova Studynkova J, Charvat F, Jarosova K, Vencovsky J. The role of MRI in the assessment of polymyositis and dermatomyositis. Rheumatology. 2007;46(7):1174–9. Epub 2007/05/15.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Sontheimer, C., Brandling-Bennett, H.A. (2016). Autoimmune Skin Disorders (Collagen Vascular). In: Hogeling, M. (eds) Case-Based Inpatient Pediatric Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-31569-0_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-31569-0_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-31567-6
Online ISBN: 978-3-319-31569-0
eBook Packages: MedicineMedicine (R0)